Kumar, R., S. K. Singh, S. Singh, and A. Kumar. “Addressing Cardio-Metabolic Risks in Type 2 Diabetes: Evidence-Based Insights on Efpeglenatide”. International Journal of Basic & Clinical Pharmacology, vol. 14, no. 4, June 2025, pp. 565-82, doi:10.18203/2319-2003.ijbcp20251843.